3

Two Vials, One Workflow: Why Reconstitution Solutions Are Ordered Separately From the Peptide

One of the first surprises for a new laboratory assistant is that a peptide and its reconstitution solution almost never…

One of the first surprises for a new laboratory assistant is that a peptide and its reconstitution solution almost never arrive as a single prepared unit. The lyophilised vial and the diluent are listed, packed and documented as two distinct catalogue items, even when they are bought on the same order and used in the same in-vitro experiment. That separation is not an administrative quirk or a gap in the product range. It reflects the physical behaviour of lyophilised powders, the storage conditions each component needs, the way batch documentation is structured, and the division of responsibility between supplier and researcher. Understanding the reasoning behind it turns a minor procedural annoyance into a useful training moment, because it teaches correct handling, traceability and compliance habits at the same time. Everything described here is laboratory workflow only: materials supplied by Research Sciences are research-use-only and are not for human or veterinary use, nor for diagnostic or therapeutic application.

Stability First: Why Lyophilised Peptides and Aqueous Diluents Travel Apart

The most immediate reason for separate ordering is physical. The peptides in the current catalogue — Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg, BPC-157 10mg and MT-1 10mg among them — are supplied as lyophilised powders. A freeze-dried solid is stable in a way an aqueous preparation is not. The published handling guide asks researchers to store lyophilised peptides at –20°C or below, sealed with desiccant and protected from moisture, heat and light. A reconstituted preparation cannot be held under those conditions without freezing the aqueous phase, so its short-term storage window shifts to 2–8°C for laboratory use. If a supplier were to combine powder and diluent before dispatch, the material would arrive already inside that shorter window, with transit time consuming part of it and no practical way for the receiving laboratory to verify how much remained.

The second reason is experimental control. In an in-vitro assay, diluent volume determines working concentration, and that volume is chosen by the researcher for the specific plate, buffer system or analytical method in front of them. A pre-mixed vial would fix that variable at the supplier’s bench rather than the researcher’s bench. The free reconstitution calculator described on product pages and in the FAQs — working in mg, mcg, mL and U-100 or U-50 syringe scales, with optional IU conversion where a factor is known — exists to support exactly this kind of laboratory arithmetic. It is a research calculation aid only and must never be used for human or veterinary dosing.

There is also a practical contamination argument. Aqueous diluents such as the 10ml Mixing Water and Bacteriostatic Water 10ml entries (both wordings appear in the catalogue) are opened repeatedly across a series of experiments. Keeping the diluent as its own sealed item, decanted or aliquoted as the protocol requires, is cleaner than drawing from a container that was opened weeks earlier during packing. Note too that the shop states all peptides contain trace amounts of mannitol as an excipient — present to aid lyophilisation, solubility and stability, not as a substitute for a diluent. None of these materials are for human or veterinary use.

Documentation and Compliance: What Separate Line Items Teach About Traceability

Separate ordering also maps cleanly onto separate documentation. Each vial label carries a reference combining the SKU code and expiry date, for example a format such as BPC10-03/27, which links back to the corresponding certificate. When the peptide and the diluent are recorded as two lines on the order, two labels on the bench and two entries in the freezer log, an auditor or supervisor can follow each item from delivery to use without inference. Bundle them into one opaque “kit” line and that correspondence becomes something the assistant has to reconstruct from memory.

Training should include reading the certificate before the first vial is opened. The shop states that a CoA accompanies every product, covering HPLC purity and identity, and its published testing framework describes purity, identity, heavy-metal and endotoxin evaluation. The homepage lists CoAs Janoshik Analytical Reports, and published purity is quoted at ≥99% (HPLC) with the exact figure stated per batch — always open the CoA for the specific batch in hand and reconfirm the current wording on the live site rather than relying on a headline figure. Two cautions belong in the induction notes: restocked products may share an Internal Test Reference with earlier stock, and an ITR links to associated sample reports without confirming that separate deliveries came from the same production lot; and vial cap colour is not an indicator of identity, analytical quality or manufacturing origin.

Compliance habits follow the same pattern. Products are labelled “For Research Use Only – Not for Human Consumption”, which the shop describes as its stated position in line with MHRA guidance, and they are not medicines, medical devices, injectables, treatments or food supplements. The purchaser is responsible for lawful use, safe handling, storage, disposal and COSHH compliance. A new assistant comparing the peptide entry with the diluent entry on Peptides uk sees two labelled items with two sets of handling notes, rather than one ambiguous package — a small detail that reinforces the research-use-only boundary from day one.

From Order to Bench: A Training Sequence for Separate Ordering and In-Vitro Handling

Before the order is placed

Confirm the intended application is lawful, in-vitro and suitable for the material, then check the exact listing — including which diluent wording appears, since Mixing Water and Bacteriostatic Water are described differently. Add a storage container if the protocol needs one. Note that the shop states it does not supply blended peptides and recommends buying individual peptides and combining them only within a controlled experimental design.

On arrival

Allow vials to reach ambient temperature before opening, as the published handling guidance advises. Match each label against its CoA and record the reference. Store lyophilised peptide at –20°C or below with desiccant, and keep the diluent under its own labelled conditions. Orders are dispatched the next working day and shipped via Royal Mail Tracked 24, which usually delivers the following working day as a carrier estimate only; the homepage “24hr UK Delivery” line should not be read as a guarantee, particularly in peak periods. There are no returns once dispatched, with refunds only for damage, incorrect supply or quality issues under the Refunds & Returns Policy.

At the bench

Work in a clean environment, remove only the amount required for the experiment, and record the diluent volume and resulting concentration alongside the assay record. Avoid repeated freeze–thaw cycles, and hold any reconstituted material at 2–8°C for short-term laboratory use only. Every step stays inside an in-vitro research workflow: these materials are not for human or veterinary use, and no handling note here should be read as dosing, administration or clinical guidance.

admin

Doha-born innovation strategist based in Amsterdam. Tariq explores smart city design, renewable energy startups, and the psychology of creativity. He collects antique compasses, sketches city skylines during coffee breaks, and believes every topic deserves both data and soul.